Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show

Aruna Bio to Present at the 31st Annual Piper Jaffray Healthcare Conference


Aruna Bio, Inc., a leader in the development of neural exosomes for the treatment of neurodegenerative diseases, today announced that Dr. Mark Sirgo, Chief Executive Officer, and Dr. Steve Stice, Chief Scientific Officer, will be presenting at the 31st Annual Piper Jaffray Healthcare Conference in New York City on Thursday, December 5th at 8:10 AM Eastern time.

Drs. Sirgo and Stice will discuss the utilization of neural exosomes as both a therapeutic and a delivery vehicle to treat neurodegenerative diseases and stroke. The presentation will include data on Aruna Bio's proprietary neural exosome platform, which has demonstrated therapeutic benefit in multiple animal models of stroke and is also being developed for the treatment of amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. Dr. Sirgo will also discuss the company's going forward strategy and key milestones for 2020.

About Aruna Bio
Aruna Bio is harnessing the natural abilities of neural exosomes to cross the blood brain barrier and enhance the body's anti-inflammatory, self-repair and protective mechanisms to treat a range of neurodegenerative disorders. Aruna Bio is also leveraging its proprietary exosomes and manufacturing platform to create synergistic therapies by enhancing exosomes with RNA, oligonucleotides, antibodies and small molecules. www.arunabio.com


These press releases may also interest you

at 14:08
Seacoast Laboratory Data Systems Announces new KPI Report Dashboard for SurroundLab AR
Seacoast Laboratory Data Systems, a nationwide leader in providing customizable LIS and AR software solutions for commercial and...

at 14:05
The Atrium at Cardinal Drive Assisted Living Community Named One of the Country's Best by U.S. News & World Report for Second Straight Year
The Atrium at Cardinal Drive, a Benchmark Mind & Memory Care community, has ranked among the best assisted living with memory care communities in Massachusetts and the entire U.S. for the second straight year. In U.S. News & World Report's third...

at 14:04
ADLM announces 2024 award winners; celebrates achievements in laboratory medicine
The Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) is proud to announce the recipients of the 2024 ADLM and Academy of Diagnostics & Laboratory Medicine Awards. Through this annual awards program, ADLM and its Academy...

at 14:04
FDA Approves New Treatment for Uncomplicated Urinary Tract Infections
Today, the U.S. Food and Drug Administration approved Pivya (pivmecillinam) tablets for the treatment of female adults with uncomplicated urinary tract infections (UTIs) caused by susceptible isolates of Escherichia coli, Proteus mirabilis and...

at 14:00
Help at Home Acknowledges CMS Efforts to Enhance Quality, Accountability and Transparency in "Ensuring Access to Medicaid Services Final Rule"
Help at Home, the leading national provider of innovative, high-quality, home care services, today announced that it is encouraged by the Administration's continued recognition of the value of the home care industry and its critical role in support...

at 13:46
VETIGEL Now Available Through All Major U.S. Distributors of Veterinary Products and Services
Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced it has entered into distribution agreements for VETIGEL® to be sold through several leading regional distributors of...

More news about Health...


News published on and distributed by: